Actinic Keratosis Treatment Market Synopsis:
The developments in the healthcare sector, in conjunction with increasing expenditure on medical facilities, is expected to generate demand for effective treatments for actinic keratosis. Market Research Future (MRFR)’s assessment reveals that the global actinic keratosis treatment market size is expected to exhibit a CAGR of 4% during the forecast period 2018 to 2024. According to the projection, the valuation of the market is anticipated to reach USD 6,088.4 Mn by 2024 up from USD 4,591.4 Mn in 201.
People are getting aware of the risk of skin cancer associated with actinic keratosis. This, in turn, is anticipated to revolutionize the growth pattern of the market over the next couple of years. Factors such as prolonged UV radiation exposure, rising geriatric population, etc. are likely to boost the revenue creation of the actinic keratosis treatment market in the foreseeable future.
Technological innovations are projected to support the growth trajectory of the market over the next couple of years. In addition, the positive results of clinical trials are anticipated to unleash immense developmental opportunities into the actinic keratosis treatment market in the years to come. However, the high cost of the treatment remains an impediment to market growth.
Get a FREE Sample Copy of Report with Complete TOC @ https://www.marketresearchfuture.com/sample_request/2366
Actinic Keratosis Treatment Market Segmentation:
Global Actinic Keratosis Treatment Market, by Type
- Medications
- Fluorouracil Cream
- Imiquimod Cream
- Ingenol Mebutate Gel
- Diclofenac Gel
- Procedures
- Cryotherapy
- Photodynamic Therapy
- Laser
- Chemical Peel
- Others
Global Actinic Keratosis Treatment Market, by End User
- Hospitals & Oncology Centers
- Dermatology Clinics
- Ambulatory Surgical Center
Actinic Keratosis Treatment Market Regional Analysis:
By region, the global actinic keratosis treatment market has been segmented into five regions – North America, Asia Pacific, South America, Europe, and the Middle East and Africa (MEA). North America resonates strong potential for growth and is anticipated to expand at a healthy rate over the projection period. The presence of prominent players in the region is poised to favor market expansion in the forthcoming years.
Asia Pacific is another important regional segment. It is projected to expand at a moderate CAGR over the forecast period. The increasing patient population in the region is the primary reason for the growth of the actinic keratosis treatment market. In addition, the developments in healthcare services are also poised to catapult the regional market on upward trajectory.
Actinic Keratosis Treatment Market Competitive Dashboard:
The key players of the actinic keratosis treatment market are Alma Lasers, Stanford Chemicals, 3M, Galderma S.A, Sun Pharmaceutical Industries Ltd., Leo Pharma, BioLineRx, Valeant Pharmaceuticals, Cipher Pharmaceuticals Inc, and Biofrontera AG.
Actinic Keratosis Treatment Industry News:
In January 2019, Biofrontera AG, an international biopharmaceutical company, announced that it has received approvals from the U.S. Food and Drug Administration (FDA), and the European Medicines Agency (EMA) for upscaling batch size for Ameluz® to 35 kg from 7 kg. Biofrontera focuses on the production of products for the treatment of actinic keratoses.
In July 2018, Almirall, S.A., a Spanish pharmaceutical company, announced positive results of phase 3 trials of KX2-391 for actinic keratosis (AK).
Browse the market data and information spread across 95 pages with 60 data tables and 14 figures of the report “Global Actinic Keratosis Treatment Market: Information by Type (Medications and Procedures), End User (Hospitals & Oncology Centers, Dermatology Clinics and Ambulatory Surgical Center) and Region (Americas, Europe, Asia-Pacific, and the Middle East & Africa) – Forecast till 2024” in-depth alongside table of content (TOC) at: https://www.marketresearchfuture.com/reports/actinic-keratosis-treatment-market-2366
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312